Document is current

Any future updates will be listed below

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

Crossref DOI link: https://doi.org/10.1007/s12072-017-9788-z

Published Online: 2017-02-16

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark